David MD - Amgen Ex RD

AMGN Stock  MXN 5,595  190.00  3.28%   

Insider

David MD is Ex RD of Amgen Inc
Age 60
Phone805 447 1000
Webhttps://www.amgen.com

Amgen Management Efficiency

The company has return on total asset (ROA) of 0.0997 % which means that it generated a profit of $0.0997 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 1.2647 %, meaning that it generated $1.2647 on every $100 dollars invested by stockholders. Amgen's management efficiency ratios could be used to measure how well Amgen manages its routine affairs as well as how well it operates its assets and liabilities.
Amgen Inc has accumulated 37.35 B in total debt with debt to equity ratio (D/E) of 309.3, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Amgen Inc has a current ratio of 2.71, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Amgen until it has trouble settling it off, either with new capital or with free cash flow. So, Amgen's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Amgen Inc sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Amgen to invest in growth at high rates of return. When we think about Amgen's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

BCom BCommMcEwen Mining
46
Engineer SnchezHoteles City Express
N/A
James GeraceVerizon Communications
59
Raj HazraMicron Technology
N/A
Juan VzquezHoteles City Express
N/A
Samantha HammockVerizon Communications
44
Anand BahlMicron Technology
N/A
Linnie HaynesworthMicron Technology
N/A
Alberto SalazarHoteles City Express
N/A
Robert KastelicMcEwen Mining
N/A
Jose CelorioGrupo Sports World
39
Courtney JDMicron Technology
46
Tamara ErwinVerizon Communications
58
Stefan BScMcEwen Mining
41
Kyle MaladyVerizon Communications
55
Sharawn ConnorsMicron Technology
N/A
Baltasar TrujilloHoteles City Express
N/A
Mihaela IancuMcEwen Mining
N/A
Farhan AhmadMicron Technology
N/A
Fabian BifarettiGrupo Sports World
59
Mary WrightMicron Technology
57
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. Amgen Inc. was founded in 1980 and is headquartered in Thousand Oaks, California. AMGEN INC operates under Drug Manufacturers - Major classification in Mexico and is traded on Mexico Stock Exchange. It employs 21500 people. Amgen Inc (AMGN) is traded on Mexican Exchange in Mexico and employs 25,200 people.

Management Performance

Amgen Inc Leadership Team

Elected by the shareholders, the Amgen's board of directors comprises two types of representatives: Amgen inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Amgen. The board's role is to monitor Amgen's management team and ensure that shareholders' interests are well served. Amgen's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Amgen's outside directors are responsible for providing unbiased perspectives on the board's policies.
Linda Louie, VP Officer
Robert Bradway, Chairman, CEO and President Chairman of Executive Committee and Member of Equity Award Committee
Murdo Gordon, Executive Vice President of Global Commercial Operations
Peter Griffith, Ex CFO
Esteban Santos, Executive Vice President Operations
Jonathan Graham, Senior Vice President General Counsel, Secretary
Nancy Grygiel, Sr Officer
Mike Zahigian, VP Officer
David MD, Ex RD
Arvind Sood, IR Contact Officer

Amgen Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Amgen a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Amgen Stock Analysis

When running Amgen's price analysis, check to measure Amgen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amgen is operating at the current time. Most of Amgen's value examination focuses on studying past and present price action to predict the probability of Amgen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amgen's price. Additionally, you may evaluate how the addition of Amgen to your portfolios can decrease your overall portfolio volatility.